Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alpaslan Tasdogan

Showing results (31-40 of 98) with videos related to

Pageof 10
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 29, 2026
Diagnostic and prognostic parameters for immune checkpoint inhibitor-related myocarditis: A meta-analysisTobias Lerchner, Florian Buehning, Julia Vogel, et al.
Neoplasia (New York, N.Y.)|February 21, 2026
Corrigendum to "U-RT1 - A new model for Richter transformation" [Neoplasia Volume 23, Issue 1, January 2021, Pages 140-148]Teresa Schmid, Julia Maier, Melanie Martin, et al.
Elife|January 20, 2021
Metabolomic profiling of rare cell populations isolated by flow cytometry from tissuesAndrew W DeVilbiss, Zhiyu Zhao, Misty S Martin-Sandoval, et al.
The Journal of Experimental Medicine|March 20, 2013
In vivo fate mapping identifies pre-TCRα expression as an intra- and extrathymic, but not prethymic, marker of T lymphopoiesisHervé Luche, Tata Nageswara Rao, Suresh Kumar, et al.
Neoplasia (New York, N.Y.)|December 14, 2020
U-RT1 - A new model for Richter transformationTeresa Schmid, Julia Maier, Melanie Martin, et al.
Nature Reviews. Disease Primers|April 3, 2025
Cutaneous melanomaAlpaslan Tasdogan, Ryan J Sullivan, Alexander Katalinic, et al.
Cell Reports|August 29, 2019
TRPML1 Promotes Protein Homeostasis in Melanoma Cells by Negatively Regulating MAPK and mTORC1 SignalingStacy Y Kasitinon, Ugur Eskiocak, Misty Martin, et al.
British Journal of Pharmacology|June 16, 2026
Refining the treatment of immune checkpoint inhibitor-associated myocarditis: Challenges, innovations and rechallenge considerationsRaluca I Mincu, Lisa Zimmer, Dimitra Vlachopoulou, et al.
Cardio-Oncology (London, England)|June 17, 2026
Cardiac dysfunction during immune checkpoint inhibitor therapy: association with extracardiac immune-related adverse eventsRaluca I Mincu, Lena Lampe, Lars Michel, et al.
Elife|June 20, 2018
The H3K4 methyltransferase Setd1b is essential for hematopoietic stem and progenitor cell homeostasis in miceKerstin Schmidt, Qinyu Zhang, Alpaslan Tasdogan, et al.
Pageof 10

Showing results (31-40 of 98) with videos related to

Sort By:
Pageof 10
European Journal of Cancer (Oxford, England : 1990)|March 29, 2026
Diagnostic and prognostic parameters for immune checkpoint inhibitor-related myocarditis: A meta-analysisTobias Lerchner, Florian Buehning, Julia Vogel, et al.
Neoplasia (New York, N.Y.)|February 21, 2026
Corrigendum to "U-RT1 - A new model for Richter transformation" [Neoplasia Volume 23, Issue 1, January 2021, Pages 140-148]Teresa Schmid, Julia Maier, Melanie Martin, et al.
Elife|January 20, 2021
Metabolomic profiling of rare cell populations isolated by flow cytometry from tissuesAndrew W DeVilbiss, Zhiyu Zhao, Misty S Martin-Sandoval, et al.
The Journal of Experimental Medicine|March 20, 2013
In vivo fate mapping identifies pre-TCRα expression as an intra- and extrathymic, but not prethymic, marker of T lymphopoiesisHervé Luche, Tata Nageswara Rao, Suresh Kumar, et al.
Neoplasia (New York, N.Y.)|December 14, 2020
U-RT1 - A new model for Richter transformationTeresa Schmid, Julia Maier, Melanie Martin, et al.
Nature Reviews. Disease Primers|April 3, 2025
Cutaneous melanomaAlpaslan Tasdogan, Ryan J Sullivan, Alexander Katalinic, et al.
Cell Reports|August 29, 2019
TRPML1 Promotes Protein Homeostasis in Melanoma Cells by Negatively Regulating MAPK and mTORC1 SignalingStacy Y Kasitinon, Ugur Eskiocak, Misty Martin, et al.
British Journal of Pharmacology|June 16, 2026
Refining the treatment of immune checkpoint inhibitor-associated myocarditis: Challenges, innovations and rechallenge considerationsRaluca I Mincu, Lisa Zimmer, Dimitra Vlachopoulou, et al.
Cardio-Oncology (London, England)|June 17, 2026
Cardiac dysfunction during immune checkpoint inhibitor therapy: association with extracardiac immune-related adverse eventsRaluca I Mincu, Lena Lampe, Lars Michel, et al.
Elife|June 20, 2018
The H3K4 methyltransferase Setd1b is essential for hematopoietic stem and progenitor cell homeostasis in miceKerstin Schmidt, Qinyu Zhang, Alpaslan Tasdogan, et al.
Pageof 10